The product called Octaplex, currently under review by the Food and Drug Administration, would reverse the effects of warfarin — an oral drug that reduces blood clotting — in cases of major bleeding.

More than 2.4 million people in the United States use warfarin to keep their blood from clotting after a heart attack, stroke or other serious thromboembolic complication. But using a blood thinner ...

LACHEN, Switzerland--(BUSINESS WIRE)--The Octapharma Group can report a record-breaking result with sales of €1.6 billion, which represents an increase of €87 million or 5.8% compared with 2015.

Octapharma Plasma says all of its more than 195 blood-plasma collection centers in 35 states nationwide — including three in Columbus — have been closed by what the company is blaming on IT "network ...

LACHEN, Switzerland--(BUSINESS WIRE)--Commenting on the Group’s results, Octapharma CEO and Chairman Wolfgang Marguerre said: “Octapharma delivered an exceptionally strong result in 2019. We achieved ...

FVIII inhibitor development is the most serious treatment complication in previously untreated patients (PUPs) with severe haemophilia A. The development of inhibitors against exogenous FVIII can ...

OTTAWA, Ontario, December 11, 2024--(BUSINESS WIRE)--Octapharma, the largest privately owned company dedicated to the research and development of life-saving or life-altering therapies, has selected ...

FRESNO COUNTY, Calif. (KFSN) -- Octapharma Plasma has closed all of its locations nationwide, including in Southeast Fresno and Clovis, citing network issues as the problem. The company pays people to ...

Octapharma has announced the publication of new data demonstrating that the fibrinogen concentrate fibryga is an effective alternative to cryoprecipitate for patients with severe bleeding during ...

A Swiss plasma product manufacturer’s U.S. division, Octapharma USA, has received a warning letter from the U.S. Food and Drug Administration over what was described as “false and misleading” ...

Octapharma Plasma launches a 32 location pilot that pays bitcoin for plasma donations. Swan Bitcoin collaborated with Spade Payment Solutions in order to create a smooth user experience that simply ...

Employers beware. In Roque v. Octapharma Plasma Inc., a California jury delivered an award of over $11 million to an individual plaintiff in an employment discrimination case despite the absence of ...